Peripartum Cardiomyopathy Awareness Month.
SCR 20
California Bills
20250SCR_002097CHP INTRODUCED 2025-02-10 PASSED_ASSEMBLY 2025-03-20 PASSED_SENATE 2025-02-27 ENROLLED 2025-03-21 CHAPTERED 2025-03-25 FILED 2025-03-25 2025 SCR CHP CHR 0 Introduced by Senator Ochoa Bogh (Coauthors: Senators Alvarado-Gil, Archuleta, Ashby, Blakespear, Cabaldon, Caballero, Cervantes, Choi, Cortese, Dahle, Durazo, Gonzalez, Grayson, Grove, Jones, Laird, Limón, McGuire, McNerney, Menjivar, Niello, Pérez, Richardson, Rubio, Seyarto, Stern, Valladares, Wahab, and Weber Pierson) LEAD_AUTHOR SENATE Ochoa Bogh COAUTHOR SENATE Alvarado-Gil COAUTHOR SENATE Archuleta COAUTHOR SENATE Ashby COAUTHOR SENATE Blakespear COAUTHOR SENATE Cabaldon COAUTHOR SENATE Caballero COAUTHOR SENATE Cervantes COAUTHOR SENATE Choi COAUTHOR SENATE Cortese COAUTHOR SENATE Dahle COAUTHOR SENATE Durazo COAUTHOR SENATE Gonzalez COAUTHOR SENATE Grayson COAUTHOR SENATE Grove COAUTHOR SENATE Jones COAUTHOR SENATE Laird COAUTHOR SENATE Limón COAUTHOR SENATE McGuire COAUTHOR SENATE McNerney COAUTHOR SENATE Menjivar COAUTHOR SENATE Niello COAUTHOR SENATE Pérez COAUTHOR SENATE Richardson COAUTHOR SENATE Rubio COAUTHOR SENATE Seyarto COAUTHOR SENATE Stern COAUTHOR SENATE Valladares COAUTHOR SENATE Wahab COAUTHOR SENATE Weber Pierson Relative to Peripartum Cardiomyopathy Awareness Month.
Peripartum Cardiomyopathy Awareness Month Peripartum Cardiomyopathy Awareness Month. This measure would designate February as Peripartum Cardiomyopathy Awareness Month. NO
WHEREAS, Peripartum cardiomyopathy (PPCM) is a form of heart failure that most often develops late in pregnancy but can occur up to five months into the postpartum period; and
WHEREAS, According to the New England Journal of Medicine, the incidence of PPCM varies from in to in pregnancies in “geographic hot spots,” such as Nigeria and Haiti, to in 1,000 to in 4,000 in Europe and the United States; and
WHEREAS, According to the federal Centers for Disease Control and Prevention, general cardiomyopathy was the cause of 9 percent of pregnancy-related deaths between and 2019, inclusive; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed in mothers without a prior diagnosis of heart disease and when no other cause of heart failure can be found; and
WHEREAS, PPCM can cause fatigue and low blood pressure due to restricted blood flow and swelling due to fluid buildup around vital organs; and
WHEREAS, PPCM is difficult to diagnosis because symptoms mimic those of a healthy pregnancy, such as shortness of breath, increased urination at night, heart palpitations, swelling in the feet and legs, and lightheadedness; and
WHEREAS, A weight gain of three pounds or more over a day or two may signal a fluid buildup that warrants a conversation with a medical professional; and
WHEREAS, Several factors increase the risk of developing PPCM, including high blood pressure, preeclampsia, multiple gestations (e.g., twins), and advanced maternal age (e.g., 35 years of age or older); and
WHEREAS, PPCM is more common amongst mothers of color and mothers diagnosed with PPCM in past pregnancies; and
WHEREAS, According to the New England Journal of Medicine, some genetic mutations including titin truncating variants may predispose some women to PPCM; and
WHEREAS, According to the American Heart Association, PPCM is diagnosed when three criteria are met: 1) heart failure develops in late pregnancy or within months following delivery; 2) left ventricular ejection fraction (the percentage of fluid ejected from the left ventricle) is less than 45 percent (typically measured by an echocardiogram); and 3) no other cause for this heart failure can be found; and
WHEREAS, Brain natriuretic peptide (BNP) and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) levels may be tested to indicate to medical providers that the heart is not pumping properly; and
WHEREAS, If caught early, many women with PPCM will recover normal heart function within six months after treatment starts; and
WHEREAS, If left untreated, PPCM can lead to advanced, lifelong heart failure which could require a heart transplant or even result in death; and
WHEREAS, PPCM treatment can include common medications that lower blood pressure, improve heart function, or reduce fluid retention, or a combination of the three, and diet changes such as restricting fluid and salt; and
WHEREAS, Women can minimize their PPCM risk by not drinking or smoking, eating a well-balanced diet, exercising, and monitoring their blood pressure;
now, therefore,
be it Resolved by the Senate of the State of California, the Assembly thereof concurring, That the Legislature proclaims the month of February as Peripartum Cardiomyopathy Awareness Month; and be it further Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.